Covered recipient · General Payments record
KASSIE SOEFJE JOHNSON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$1,360.83
- Reported across 56 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $425.29 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $227.39 | 7 |
| Novo Nordisk AS | $82.13 | 4 |
| Lilly USA, LLC | $29.69 | 2 |
| Xeris Pharmaceuticals, Inc. | $22.51 | 1 |
| Amgen Inc. | $19.25 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.83 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.42 | 1 |
| Acerta Pharma LLC | $13.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $120.01 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104002291 | CMS |
| ABBVIE INC. | $4.35 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104002293 | CMS |
| ABBVIE INC. | $18.83 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104002295 | CMS |
| ABBVIE INC. | $24.99 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104002297 | CMS |
| ABBVIE INC. | $7.71 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104002299 | CMS |
| ABBVIE INC. | $18.30 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104002301 | CMS |
| ABBVIE INC. | $33.20 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104002303 | CMS |
| Amgen Inc. | $19.25 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117289435 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.07 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105691669 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $16.83 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118225312 | CMS |
| Lilly USA, LLC | $14.30 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135092201 | CMS |
| Lilly USA, LLC | $15.39 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135099320 | CMS |
| Novo Nordisk Inc | $26.76 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096907859 | CMS |
| Novo Nordisk Inc | $23.26 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097375024 | CMS |
| Novo Nordisk Inc | $17.74 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097596703 | CMS |
| Novo Nordisk Inc | $14.37 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096685946 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.42 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153596333 | CMS |
| Xeris Pharmaceuticals, Inc. | $22.51 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144601111 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.